SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-032408
Filing Date
2008-05-28
Accepted
2008-05-28 15:45:17
Documents
1
Period of Report
2008-05-23

Document Format Files

Seq Description Document Type Size
1 v115974_ex.html 4  
1 v115974_ex.xml 4 3385
  Complete submission text file 0001144204-08-032408.txt   5265
Mailing Address 750 LEXINGTON AVENUE 6TH FLOOR NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE 6TH FLOOR NEW YORK NY 10022 212-905-0189
OPTIGENEX INC. (Issuer) CIK: 0001168776 (see all company filings)

IRS No.: 201678933 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1

Mailing Address 1 14TH STREET APT 301 HOBOKEN NJ 07030
Business Address 212 905 0189
ZWIREN DANIEL A (Reporting) CIK: 0001365372 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51248 | Film No.: 08863523